Related Experiment Video

Updated: Oct 5, 2025

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
08:44

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

2.6K

Clinical Characteristics and the Risk Factors of Hepatic Injury in 221 Children With Infectious Mononucleosis

Chao Zhang1, Shu Cui2,3, Guoshun Mao1

  • 1Department of Pediatrics, Fuyang People's Hospital, Fuyang, China.

Frontiers in Pediatrics
|January 31, 2022
PubMed

Insights

Epstein-Barr Virus infection can cause infectious mononucleosis with liver injury in children. Female gender, older age, and splenomegaly are identified as key risk factors for hepatic damage in these pediatric patients.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Hepatology

Background:

  • Infectious mononucleosis, caused by Epstein-Barr Virus (EBV), is a common childhood illness.
  • Hepatic injury affects a significant portion (40-80%) of children with infectious mononucleosis, with hepatic failure being a critical concern in severe cases.
  • Understanding the demographics, clinical features, and risk factors for hepatic injury is crucial for early identification and management in pediatric patients.

Purpose of the Study:

  • To identify the demographic characteristics of children with infectious mononucleosis.
  • To determine the clinical features associated with hepatic injury in these children.
  • To pinpoint independent risk factors for hepatic injury in pediatric infectious mononucleosis.

Main Methods:

  • A descriptive, cross-sectional study was conducted.
  • Retrospective review of 31 months of data from hospitalized children with infectious mononucleosis.
  • Collection of demographic, clinical, laboratory, and outcome data.

Main Results:

  • Out of 221 patients, 43.9% exhibited hepatic injury (defined as ALT > 40 U/L).
  • Hepatic injury was associated with higher rates of hepatomegaly, splenomegaly, palpebral edema, older age, longer hospitalization, and elevated leukocyte, lymphocyte, atypical lymphocyte counts, and AST levels.
  • Independent risk factors for hepatic injury included female gender, older age, and splenomegaly.

Conclusions:

  • Hepatic injury in children with infectious mononucleosis is linked to specific demographic and clinical factors.
  • Female gender, older age, and splenomegaly are identified as significant independent risk factors for hepatic injury.
  • This study enhances the understanding of hepatic injury risk factors in pediatric infectious mononucleosis, aiding clinical awareness.

Keywords:
Epstein-Barr viruscorrelative factorsgenderhepatic injuryinfectious mononucleosissplenomegaly

More Related Videos

Isolation of Tonsillar Mononuclear Cells to Study Ex Vivo Innate Immune Responses in a Human Mucosal Lymphoid Tissue07:38

Isolation of Tonsillar Mononuclear Cells to Study Ex Vivo Innate Immune Responses in a Human Mucosal Lymphoid Tissue

Published on: June 14, 2020

7.7K
An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection09:43

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

9.4K

Related Concept Videos

Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.2K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
28
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
38
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
17
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
140
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
10